Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 28, Issue 10, 2015, Pages 1128-1132

  Cantu, Jessica A ^a   Jauk, Victoria R ^a   Owen, John ^a   Biggio, Joseph R ^a   Abramovici, Adi R ^a   Edwards, Rodney K ^a   Tita, Alan T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Aspirin; gestational age; obesity; preeclampsia; prevention

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; ANTITHROMBOCYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANTICOAGULANT THERAPY; BODY MASS; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EARLY INTERVENTION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MATERNAL TREATMENT; OBESITY; PREECLAMPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME TO TREATMENT; COMPLICATION; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BODY MASS INDEX; FEMALE; GESTATIONAL AGE; HUMANS; OBESITY; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84940666253     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.947258     Document Type: Conference Paper

References (22)

1. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;99:159-67.
2. Benigni A, Gregorini G, Frusca T, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989;321:357-62.
3. Hauth JC, Goldenberg RL, Parker Jr CR, et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 1993;168: 1083-91.
4. Schiff E, Peleg E, Goldenberg M, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. NEJM 1989;321:351-6.
5. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of preeclampsia by early antiplatelet therapy. Lancet 1985;325:840-2.
6. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701-5.
7. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343:619-29.
8. Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993; 329:1213-8.
9. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;2:CD004659.
10. Askie L, Duley L, Henderson-Smart D, Stewart L. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007;369:1791-8.
11. Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402-14.
12. Roberts J, Bodnar L, Patrick T, Powers R. The role of obesity in preeclampsia. Pregnancy Hypertens 2011;1:6-16.
13. Yu C, Teoh T, Robinson S. Obesity in pregnancy. BJOG 2006;113: 1117-25.
14. Bodnar LM, Catov JM, Klebanoff MA, et al. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007;18:234-9.
15. Brill M, Diepstraten J, Rongen A, et al. Impact on drug metabolism and elimination in adults and children. Clin Pharm 2012;51: 277-304.
16. Lexi-Comp Online-. Hudson (OH): Lexi-Comp, Inc. Available from: www.lexi.com/ [last accessed 4 June 2014].
17. Ebrashy A, Ibrahim M, Marzook A, et al. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: a randomized controlled clinical trial. Croat Med J 2005;46:826-31.
18. Roberge S, Villa P, Nicolaides K, et al. Early administration of lowdose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012;31: 141-6.
19. Roberge S, Giguere Y, Villa P, et al. Early administration of lowdose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012;29: 551-6.
20. O'Brien T, Ray J, Chan W. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003;14: 368-74.
21. Wolf M, Kettyle E, Sandler L, et al. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98:757-62.
22. Roberts J, Catov J. Aspirin for pre-eclampsia: compelling data on benefit and risk. Lancet 2007;369:1765-6.